TCL Archive Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change. September 30, 2005
TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive “The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts” October 28, 1994
